A Phase2/3, Randomized, Double-blind, Placebo-controlled, Multicenter, Prospective Study to Assess the efficacy, Safety, and Pharmacokinetics of Orally Adminstered Epetraborale in Patients with Treatment-refractory Mycobacterium avium Complex Lung Disease (MACrO2)

Jenkin, Grant (Primary Chief Investigator (PCI))

Medicine Monash Health

Project: Research

Project Description

HREC Reference Number: HREC/89433/MonH-2022-338641(v1)
SSA Reference Number: SSA/89433/MonH-2023-357737(v1)
Monash Health Local Reference: RES-22-0000-641A

Status	Active
Effective start/end date	14/04/23 → 13/04/28

A Phase2/3, Randomized, Double-blind, Placebo-controlled, Multicenter, Prospective Study to Assess the efficacy, Safety, and Pharmacokinetics of Orally Adminstered Epetraborale in Patients with Treatment-refractory Mycobacterium avium Complex Lung Disease (MACrO2)

Project Details

Project Description